MedPath

Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The ImPACT Program

Not Applicable
Recruiting
Conditions
Brain Cancer
Cognitive Impairment
Interventions
Behavioral: ImPACT program
Registration Number
NCT05858359
Lead Sponsor
Aarhus University Hospital
Brief Summary

The aim of the present randomized-controlled study is to evaluate the feasibility, acceptability, and preliminary efficacy of a novel, context-sensitive neuropsychological rehabilitation intervention for brain cancer survivors.

Detailed Description

Cognitive impairment is the most common late effect in brain cancer survivors, with profound negative effects on quality of life, work ability, and socioeconomic outcomes. Still, there is no gold standard approach to treating cognitive impairment in brain cancer survivors. Furthermore, there is a dearth of research on interventions to treat cognitive impairment in brain cancer survivors, and the relatively few studied interventions have proven limited effects. Arguably, four key elements are missing from a majority of studied interventions:1) transfer of learning to real-world functional outcomes, 2) awareness training to enhance compensatory strategy use, 3) inclusion of carers that could enhance transfer of learning to the home, and 4) recognition of the inter-related nature of cognitive, neurobehavioral, and psychological functions.

The "I'M aware: Patients and Carers Together (ImPACT)" program is a novel, context-sensitive neuropsychological rehabilitation intervention that targets the above mentioned missing elements in previous rehabilitation efforts. The present feasibility randomized-controlled study aims to evaluate the feasibility, acceptability, and preliminary efficacy of this program in brain cancer survivors with cognitive impairment in preparation for a subsequent large-scale randomized controlled trial.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Diagnosis of brain cancer
  • Completed primary treatment at least 6 months ago
  • Medically stable
  • Speaks and understand Danish
  • Living with a carer aged 18 or over, who also speaks and understands Danish and consents to participate in the study alongside the patient
Exclusion Criteria

• Confounding diagnosed or suspected psychiatric or medical condition unrelated to the cancer or its treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ImPACT programImPACT programThe ImPACT program consists of 8 weekly 1-hour sessions with homework between sessions.
Primary Outcome Measures
NameTimeMethod
Self-reported cognitive functioningBaseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)

The Patients Assessment of Own Functioning Inventory (PAOFI). 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.

Carer-reported cognitive functioningBaseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)

The Patients Assessment of Own Functioning Inventory (PAOFI) modified to informant version. 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.

Carer-reported neurobehavioral functioningBaseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)

The carer-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.

Self-reported neurobehavioral functioningBaseline (T1) to after last session (approximately 8 weeks later: Post-intervention, T3)

The self-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.

Secondary Outcome Measures
NameTimeMethod
Carer-reported mental fatigueBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Mental Fatigue Scale (MFS) modified to informant version. 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.

Carer-reported health-related quality of lifeBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Functional Assessment of Cancer Therapy-Brain (FACT-Br) modified to informant version. 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.

Self-reported community integrationBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.

Self-reported cognitive functioningBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Patients Assessment of Own Functioning Inventory (PAOFI). 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.

Premorbid intellectual functioning (Patient only)Baseline (T1)

WAIS-IV Information subtest. 26 items; answer format range 0-1; total score range: 0-26. Higher score indicates higher premorbid intellectual functioning.

Self-reported fatigueBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue). 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.

Carer-reported cognitive functioningBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Patients Assessment of Own Functioning Inventory (PAOFI) modified to informant version. 33 items: answer format range 1-6; total score range: 0-33. Higher score indicates more impairment.

Carer-reported neurobehavioral functioningBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The carer-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.

Objective cognitive functioning (Neuropsychological tests; Patient only)Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

Global composite z-score based on the HVLT-R; Trail-making tests A and B; WAIS-IV Coding, Digit Span, Verbal Fluency; Conner's Continuous Performance Test III.

Depression (patient only)Baseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Center for Epidemiologic Studies Depression Scale (CESD). 20 items: answer format range 0-3; total score range: 0-60. Higher score indicates more depression.

Self-reported health-related quality of lifeBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Functional Assessment of Cancer Therapy-Brain (FACT-Br). 50 items; answer format range 0-4; total score range: 0-200. Higher score indicates better health-related quality of life.

Self-reported participant satisfactionBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.

Self-reported neurobehavioral functioningBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The self-report version of the Frontal Systems Behavior Scale (FrSBe). 46 items: answer format range 1-5; total score range: 46-230. Higher score indicates more impairment.

Self-reported mental fatigueBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Mental Fatigue Scale (MFS). 15 items: answer format range 0-3; total score range: 0-45. Higher score indicates more mental fatigue.

Carer-reported community integrationBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The self-report version of the Community Integration Questionnaire Revised (CIQ-R). 18 items: answer format range 0-2; total score range: 0-35. Higher score indicates more community integration.

Self-reported participant motivationBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.

Carer-reported fatigueBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-Fatigue) modified to informant version. 13 items: answer format range 0-4; total score range: 0-52. Lower score indicates more fatigue.

InsomniaBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Insomnia Severity Index (ISI). 7 items; answer format range: 0-4; total score range: 0-28. Higher score indicates more insomnia.

Carer-reported participant satisfactionBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The Client Satisfaction Questionnaire (CSQ-8). 8 items: answer format range 1-4; total score range: 8-32. Higher score indicates better satisfaction.

Carer-reported participant motivationBaseline (T1) to 8 week after post-intervention (approximately 16 weeks later: Follow-up, T4)]

The 7-item interest/enjoyment subscale of the Intrinsic Motivation Inventory (IMI). 7 items: answer format range 1-7; total score range: 1-7. Higher score indicates more motivation.

Trial Locations

Locations (1)

Aarhus University Hospital

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath